◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
STELLA PHARMA CORPORATION — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 12, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
+Operating Income -269.1M -301.2M -- -- --
Operating Margin % 100.7% 99.2% -- -- --
+Ordinary Income -267.3M -303.7M -- -- --
Revenue Growth % 12.0% -- -- -- --
Line ItemQ4 2025Nov 14, 2025Q4 2024Nov 12, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022
Current Assets 5.2B 3.6B -- -- --
Total Assets 5.4B 3.8B 4.1B 4.4B 5.4B
Current Liabilities 390.4M 455.6M -- -- --
Total Liabilities 2.2B 1.4B 1.3B 1.6B 1.8B
Total Equity 3.2B 2.4B 2.8B 2.9B 3.6B
Equity Ratio -- -- 0.68 0.65 0.67
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...